Primary Care Diabetes
Volume 3, Issue 4 , Pages 253-257 , November 2009

A survey of treatment practices in diabetic peripheral neuropathy

  • Carl J. Possidente

      Affiliations

    • Pfizer, Inc., PO Box 1021, Jericho Center, VT 05465, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 802 899 1146; fax: +1 802 899 1146.
    • ,
  • Rup Tandan

      Affiliations

    • University of Vermont, College of Medicine, 89 Beaumont Ave, Room C225 Given Building, Burlington, VT 05405, United States
    • Tel.: +1 802 656 4588.

Received 15 May 2009 ,Revised 18 August 2009 ,Accepted 25 August 2009.

References 

  1. American Diabetes Association, National Diabetes Fact Sheet, available at: http://www.diabetes.org/diabetes-statistics.jsp (accessed January 23, 2009).
  2. Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the U.S.. Diab. Care. 2003;26:1790–1795
  3. Argoff C, Cole B, Fishbain D, Irving G. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin. Proc. 2006;81(4 Suppl.):S3–S11
  4. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diab. Care. 2006;29:1518–1522
  5. Sadosky A, McDermott A, Brandenburg N, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract. 2008;8:45–56
  6. Zelman D, Gore M, Dukes E, et al. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. J. Pain Symptom Manage. 2005;29:401–410
  7. Tolle T, Xu X, Sadosky A. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J. Diab. Complications. 2006;20:26–33
  8. Sommer C, Geis C, Haanpaa M, et al. Questionnaire on neuropathic pain: a European neurologist survey. Neurol. Sci. 2007;28:136–141
  9. American Diabetes Association, Standards of Medical Care in Diabetes: 2009, Diab. Care 32 (1 Suppl.) (2009) S13–S61.
  10. Boulton A, Vinik A, Arezzo J, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diab. Care. 2005;28:956–962
  11. Argoff C, Backonja M, Belgrade M, et al. Consensus guidelines: treatment planning and options. Mayo Clin. Proc. 2006;81(4 Suppl.):S12–S25
  12. Gore M, Brandenburg N, Hoffman D, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J. Pain. 2006;7:892–900
  13. Berger A, Dukes E, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J. Pain. 2004;5:143–149
  14. Giannopoulos S. Burden of illness in painful diabetic peripheral neuropathy. J. Pain. 2007;8:530;(letter)

☆ This project was presented as a poster at the American Academy of Pain Management's 19th Annual Clinical Meeting in Nashville, TN, September 2008.

PII: S1751-9918(09)00088-6

doi: 10.1016/j.pcd.2009.08.008

Primary Care Diabetes
Volume 3, Issue 4 , Pages 253-257 , November 2009

Article Tools